About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  HISTORICAL VOLUME
Historical Volume      
Medicamen Biotech Ltd.
BSE Code 531146
ISIN Demat INE646B01010
Book Value 197.62
NSE Code MEDICAMEQ
Dividend Yield % 0.40
Market Cap 3363.58
P/E 38.02
EPS 6.52
Face Value 10  
Exchange : Period From : Period To :
DateOpen Price(Rs.)High Price(Rs.)Low Price(Rs.)Close Price(Rs.)VolumeTurnover
28-Apr-2026 255.90 256.50 245.95 248.00 194 49209
27-Apr-2026 259.70 265.40 247.55 253.20 1687 429189
24-Apr-2026 259.45 259.45 254.20 256.40 1294 330358
23-Apr-2026 268.80 268.80 256.50 257.10 1186 312814
22-Apr-2026 261.70 272.00 261.70 268.30 940 248579
21-Apr-2026 269.15 269.15 260.00 261.70 705 186685
20-Apr-2026 259.05 272.10 258.50 267.20 6938 1867819
17-Apr-2026 253.55 261.10 252.15 258.50 790 203510
16-Apr-2026 289.00 289.00 244.85 248.50 2748 686981
15-Apr-2026 246.25 255.70 245.25 246.80 1139 286180
13-Apr-2026 235.00 249.95 232.50 242.55 596 145468
10-Apr-2026 241.55 247.75 237.00 242.45 1618 393156
09-Apr-2026 240.05 243.45 236.75 238.50 2459 592817
08-Apr-2026 233.50 245.90 233.15 240.45 2249 541264
07-Apr-2026 225.85 237.40 222.50 226.85 2995 684943
06-Apr-2026 231.80 234.20 225.05 226.70 1629 373531
02-Apr-2026 227.45 239.65 225.25 230.85 2384 556661
01-Apr-2026 234.35 246.50 230.00 234.85 6613 1568070
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.